期刊文献+

造血干细胞移植后人巨细胞病毒动态监测的临床意义

Clinical Significance of Monitoring of Human Cytomegalic Inclusion Disease Virus after Haemopoietic Stem Cell Transplantation
下载PDF
导出
摘要 【目的】探讨造血干细胞移植(HSCT)术后巨细胞病毒(CMV)感染的监测方法及意义。【方法】对40例进行HSCT的患者采用实时聚合酶链反应(PCR)技术定量动态监测白细胞中巨细胞病毒(CMV)DNA载量并进行比较分析。【结果】40例进行HSCT的患者中有12例出现阳性,阳性率为30.00%。1例死亡,病死率为2.50%。12例阳性患者均经CMV抗病毒治疗,其中1例死亡,11例转阴。阳性结果持续次数最长为21 d,最短为7 d。【结论】动态监测巨细胞病毒感染状况在移植群体中有着重要的价值。 [Objective] To discuss the ways of monitoring cytomegalovirus(CMV) infection after haemopoietic stem cell transplantation (HSCT) and its significance. [Methods]Real-time polymerase chain reaction technique was used to monitor DNA quantity of CMV in white blood cell and the comparison was made. [Results]Among 40 patients, there were 12 patients with high DNA quantity of cytomegalic inclusion disease virus beyond normal value, and the positive rate was 30.00%. One patient was dead, and the case fatality ratio was 2.50%. After anti-CMV therapy, there was 1 death, and CMV of another 11 patients was negative. The number of times of positive findings was 1 and 4, respectively, correspond to the longest and shortest. There was no marked change in results of 1 death. [Conclusion]The dynamic monitoring of CMV infection has important value for transplantation group.
作者 李雷 张葵
出处 《医学临床研究》 CAS 2008年第12期2196-2198,共3页 Journal of Clinical Research
关键词 造血干细胞移植 巨细胞病毒属 hematopoietic stem cell transplantation cytomegalovirus
  • 相关文献

参考文献2

二级参考文献49

  • 1Liang-HuiGao Shu-SenZheng.Cytomegalovirus and chronic allograft rejection in liver transplantation[J].World Journal of Gastroenterology,2004,10(13):1857-1861. 被引量:8
  • 2丛敏,阎钟钰,王萍,张岩,徐雍,卢炎,王宝恩,贾继东,尤红.荧光定量聚合酶链反应检测基质金属蛋白酶组织抑制因子-1方法的建立[J].中华检验医学杂志,2005,28(5):533-537. 被引量:6
  • 3Demetris A, Adams D, Bellamy C, Blakolmer K, Clouston A,Dhillon AP, Fung J, Gouw A, Gustafsson B, Haga H, Harrison D, Hart J, Hubscher S, Jaffe R, Khettry U, Lassman C, Lewin K, Martinez O, Nakazawa Y, Neil D, Pappo O, Parizhskaya M, Randhawa P, Rasoul-Rockenschaub S, Reinholt F, Reynes M, Robert M, Tsamandas A, Wanless I, Wiesner R, Wernerson A, Wrba F, Wyatt J, Yamabe H. Update of the international banff schema for liver allograft rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. Hepatology 2000; 31:792-799.
  • 4Jaln D, Robert ME,Navarro V, Friedman AL, Crawford JM. Total fibrous obliteration of main portal vein and portal foam cell venopathy in chronic hepatic allograft rejection. Arch Pathol Lab Med 2004; 128:64-67.
  • 5Wiesner RH, Ludwig J, van Hoek B, Krom RA. Current concepts in cell-mediated hepatic allograft rejection leading to ductopenia and liver failure. Hepatology 1991; 14(4 Pt 1): 721-729.
  • 6Demetris AJ, Markus BH, Esquivel C, Van Thiel DH, Saidman S,Gordon R, Makowka L, Sysyn GD, Starzl TE. Pathologic analysis of liver transplantation for primary biliary cirrhosis. Hepatology 1988; 8:939-947.
  • 7Gubernatis G, Kemnitz J, Tusch G, Pichlmayr R. HLA compatibility and different features of liver allograft rejection. Transpl Int 1988; 1:155-160.
  • 8Manez R, White LT, Linden P, Kusne S, Martin M, Kramer D,Demetris AJ, Van Thiel DH, Starzl TE, Duquesnoy RJ. The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation. Transplantation 1993;55:1067-1071.
  • 9Bismuth A, Ducot B, Samuel D, Arulnaden JL, Gugenheim J,Debat P, Azoulay D, Farrokhi P, Pillier-Loriette C, Bourdon G.Liver transplantation and the major histocompatibility complex.Rev Fr Transfus Hemobiol 1991; 34:449-457.
  • 10Batts KP, Moore SB, Perkins JD, Wiesner RH, Grambsch PM,Krom RA. Influence of positive lymphocyte crossmatch and HLA mismatching on vanishing bile duct syndrome in human liver allografts. Transplantation 1988; 45:376-379.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部